Analysis of the Aetiological Factors of Malnutrition
NCT05781178 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271
Last updated 2024-09-19
Summary
Disease-related malnutrition (DRM) is a frequent syndrome in clinical practice, in which the mutual relationship between disease and malnutrition is observed. Inflammation, anorexia, changes in body composition or in energy and protein requirements, contribute to the development of DRM. The Global Leadership Initiative on Malnutrition (GLIM criteria) provides a diagnostic system of malnutrition that has been accepted by the main international scientific societies in the field of clinical nutrition.
The GLIM criteria proposes an algorithm that includes phenotypic criteria (weight loss, underweight and low muscle mass), with their corresponding severity thresholds, and aetiological criteria (decreased oral intake, nutrient malabsorption and the presence of an inflammatory component). The diagnosis of malnutrition is established when an aetiological and a phenotypic criterion are met.
The aim of the study is to determine the diagnostic and prognostic value of aetiological factors of malnutrition based on GLIM criteria, presence and degree of inflammation and dietary intake, in patients diagnosed with DRM.
Conditions
- Disease-related Malnutrition
- Inflammation
Interventions
- DIETARY_SUPPLEMENT
-
Oral nutritional supplement rich in omega-3 and olive oil polyphenols
Nutritional intervention with an oral nutrition supplement with anti-inflammatory effect and a programme of physical exercise
Sponsors & Collaborators
-
Adventia Pharma
collaborator INDUSTRY -
Endocrinology and Clinical Nutrition Research Center, Spain
lead OTHER
Principal Investigators
-
Daniel de Luis Roman, Prof · Endocrinology and Nutrition Department. Hospital Clínico Universitario de Valladolid (Spain)
-
Samara Palma Milla, PhD · Endocrinology and Nutrition Department. Hospital Universitario La Paz (Spain)
-
Alfonso Vidal Casariego, PhD · Endocrinology and Nutrition Department. Complejo Hospitalario Universitario de A Coruña (Spain)
-
José M García Almeida, PhD · Endocrniology and Nutrition Department. Hospital Universitario Virgen de la Victoria (Spain)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-02
- Primary Completion
- 2024-05-17
- Completion
- 2024-09-11
Countries
- Spain
Study Locations
More Related Trials
-
Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders
NCT01985178 ·Status: COMPLETED ·Phase: NA
-
Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition
NCT03245749 ·Status: COMPLETED
-
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
NCT01746303 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids and Exercise on Mobility and Cognition in Older Women
NCT03228550 ·Status: COMPLETED ·Phase: PHASE2
-
Intervening to Repair Cognitive and Behavioural Problems in Adults Exposed to Childhood Malnutrition
NCT04053218 ·Status: UNKNOWN ·Phase: PHASE3
-
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
NCT02553915 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children
NCT01323283 ·Status: COMPLETED ·Phase: NA
-
Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa
NCT01761942 ·Status: UNKNOWN ·Phase: PHASE2
-
B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy.
NCT07312435 ·Status: RECRUITING ·Phase: NA
-
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline
NCT04484454 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases
NCT03072823 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897 ·Status: COMPLETED ·Phase: PHASE2
-
Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans
NCT01317290 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Multi-country Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression
NCT02529423 ·Status: COMPLETED ·Phase: NA
-
Fish Oil (Omega 3), Immune Function, and Mood
NCT00385723 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn.
NCT04151758 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
NCT01803711 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Clinical Study of Omega-3 on Depression and Cognition
NCT05941754 ·Status: UNKNOWN ·Phase: NA
-
Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
NCT00511810 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Omega-3 as a Treatment for Major Depression
NCT00238758 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder.
NCT03732378 ·Status: COMPLETED ·Phase: NA
-
Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae
NCT04278482 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression
NCT04803071 ·Status: UNKNOWN ·Phase: NA
-
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
NCT01055119 ·Status: COMPLETED ·Phase: NA